Choreo LLC Has $3.69 Million Stock Position in Danaher Corporation $DHR

Choreo LLC grew its stake in Danaher Corporation (NYSE:DHR) by 23.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,636 shares of the conglomerate’s stock after buying an additional 3,493 shares during the quarter. Choreo LLC’s holdings in Danaher were worth $3,687,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the stock. Red Tortoise LLC boosted its stake in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the period. Ramirez Asset Management Inc. bought a new stake in shares of Danaher in the second quarter valued at about $40,000. Costello Asset Management INC acquired a new position in shares of Danaher during the first quarter worth about $41,000. Strengthening Families & Communities LLC boosted its position in shares of Danaher by 81.4% during the first quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after buying an additional 114 shares during the period. Finally, Saudi Central Bank bought a new position in shares of Danaher during the first quarter worth about $52,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several research reports. Bank of America cut their target price on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a report on Tuesday, September 2nd. TD Cowen boosted their price objective on shares of Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of Danaher from $235.00 to $250.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $243.39.

Danaher Stock Performance

Shares of DHR opened at $228.41 on Friday. The company has a market cap of $161.33 billion, a PE ratio of 47.09, a price-to-earnings-growth ratio of 3.28 and a beta of 0.81. The firm has a 50-day moving average of $211.54 and a 200-day moving average of $202.99. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10.

Danaher (NYSE:DHR) last issued its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same period in the prior year, the firm earned $1.71 EPS. Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s payout ratio is currently 26.39%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. The trade was a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total transaction of $1,088,713.08. Following the completion of the transaction, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.